High materiality7/10
Viking Therapeutics price target lowered to $85 from $87 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst Truist lowers VKTX PT to $85; current price about $28.82; implies upside potential remains.
- PT: $85; Price: $28.82; Upside potential remains.
Key facts
- 01
Target: $85
- 02
Posted price: $28.82
- 03
Analyst firm: Truist Financial
- 04
Analyst: Gregory Renza
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.